These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 2668351)

  • 1. Effect of benazepril monotherapy in subjects with hypertension associated with renal dysfunction.
    Reams GP; Lau A; Bauer JH
    J Clin Pharmacol; 1989 Jul; 29(7):609-14. PubMed ID: 2668351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic and renal effects of a new angiotensin converting enzyme inhibitor, benazepril, in essential hypertension.
    Valvo E; Casagrande P; Bedogna V; Antiga L; Alberti D; Zamboni M; Perobelli L; Dal Santo F; Maschio G
    J Hypertens; 1990 Nov; 8(11):991-5. PubMed ID: 1963190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of the combination of valsartan and benazepril in patients with chronic renal disease. European Group for the Investigation of Valsartan in Chronic Renal Disease.
    Ruilope LM; Aldigier JC; Ponticelli C; Oddou-Stock P; Botteri F; Mann JF
    J Hypertens; 2000 Jan; 18(1):89-95. PubMed ID: 10678548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lisinopril monotherapy on renal hemodynamics.
    Reams GP; Bauer JH
    Am J Kidney Dis; 1988 Jun; 11(6):499-507. PubMed ID: 2837083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antihypertensive activity and renal effects of benazepril in humans.
    Tramonti G; Donadio C; Confessore N; Bianchi C
    Kidney Int Suppl; 1996 Jun; 55():S107-8. PubMed ID: 8743526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of hypertension and effects of benazepril hydrochloride in a canine remnant kidney model of chronic renal failure.
    Mishina M; Watanabe T
    J Vet Med Sci; 2008 May; 70(5):455-60. PubMed ID: 18525166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of cilazapril on renal function and hormones in hypertensive patients with renal disease.
    Swainson CP; Walker RJ; Bailey RR
    Am J Med; 1989 Dec; 87(6B):83S-87S. PubMed ID: 2532467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.
    Maschio G; Alberti D; Janin G; Locatelli F; Mann JF; Motolese M; Ponticelli C; Ritz E; Zucchelli P
    N Engl J Med; 1996 Apr; 334(15):939-45. PubMed ID: 8596594
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short- and long-term effects of spirapril on renal hemodynamics in patients with essential hypertension.
    Reams GP; Lau A; Knaus V; Bauer JH
    J Clin Pharmacol; 1993 Apr; 33(4):348-53. PubMed ID: 8473550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal functional reserve in patients with essential hypertension: effect of inhibition of the renin--angiotensin system.
    Valvo E; Casagrande P; Bedogna V; Dal Santo F; Alberti D; Fontanarosa C; Braggio P; Maschio G
    Clin Sci (Lond); 1990 Jun; 78(6):585-90. PubMed ID: 2165891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cilnidipine is as effective as benazepril for control of blood pressure and proteinuria in hypertensive patients with benign nephrosclerosis.
    Rose GW; Kanno Y; Ikebukuro H; Kaneko M; Kaneko K; Kanno T; Ishida Y; Suzuki H
    Hypertens Res; 2001 Jul; 24(4):377-83. PubMed ID: 11510750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiotensin-converting enzyme inhibition on plasma aldosterone concentration, plasma renin activity, and blood pressure in spontaneously hypertensive cats with chronic renal disease.
    Steele JL; Henik RA; Stepien RL
    Vet Ther; 2002; 3(2):157-66. PubMed ID: 19750747
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of aldosterone blockade in resistant hypertension associated with chronic kidney disease.
    Pisoni R; Acelajado MC; Cartmill FR; Dudenbostel T; Dell'Italia LJ; Cofield SS; Oparil S; Calhoun DA
    J Hum Hypertens; 2012 Aug; 26(8):502-6. PubMed ID: 21677673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effectiveness and tolerance of benazepril versus captopril in patients with hypertension].
    Ol'binskaia LI; Golubev SA; Morozova TE
    Klin Med (Mosk); 1995; 73(5):36-8. PubMed ID: 8815273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of ramipril and telmisartan on serum potassium and its association with cardiovascular and renal events: results from the ONTARGET trial.
    Heerspink HJ; Gao P; de Zeeuw D; Clase C; Dagenais GR; Sleight P; Lonn E; Teo KT; Yusuf S; Mann JF
    Eur J Prev Cardiol; 2014 Mar; 21(3):299-309. PubMed ID: 24191305
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive hypotensive effect of angiotensin-converting enzyme inhibition and angiotensin-receptor antagonism in essential hypertension.
    Stergiou GS; Skeva II; Baibas NM; Roussias LG; Kalkana CB; Achimastos AD; Mountokalakis TD
    J Cardiovasc Pharmacol; 2000 Jun; 35(6):937-41. PubMed ID: 10836730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
    Fan CM; Yan LR; Tao YK; Wang L; Li YQ; Gao MM; Wang YN; Li CX; Wang XW; Lu XL; Pang HM; Li YS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2011 Jan; 39(1):57-60. PubMed ID: 21418799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal outcomes in hypertensive Black patients at high cardiovascular risk.
    Weir MR; Bakris GL; Weber MA; Dahlof B; Devereux RB; Kjeldsen SE; Pitt B; Wright JT; Kelly RY; Hua TA; Hester RA; Velazquez E; Jamerson KA
    Kidney Int; 2012 Mar; 81(6):568-76. PubMed ID: 22189843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of enalapril monotherapy and enalapril/hydrochlorothiazide combination therapy on blood pressure, renal function, and body fluid composition.
    Reams GP; Bauer JH
    J Clin Hypertens; 1986 Mar; 2(1):55-63. PubMed ID: 3014081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Angiotensin-converting enzyme inhibitors and kidney protection: the AIPRI trial. The ACE Inhibition in Progressive Renal Insufficiency (AIPRI) Study Group.
    Maschio G; Alberti D; Locatelli F; Mann JF; Motolese M; Ponticelli C; Ritz E; Janin G; Zucchelli P
    J Cardiovasc Pharmacol; 1999; 33 Suppl 1():S16-20; discussion S41-3. PubMed ID: 10028949
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.